Drugs / Albaconozole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01014962 | Aug → Dec 2009 | tinea unguium | Stiefel, a GSK Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Albaconozole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01014962 ↗ |
| Route | Oral | “Albaconozole 400 mg oral once daily for 5 days” NCT01014962 ↗ |